PharmaMar (MSE:PHM) has signed a Memorandum of Understanding with the Research Center for Oceanography, the Indonesian Institute of Science (RCO-LIPI), in the presence of the Indonesian Ambassador in Spain, H.E. Mr. Drs. Hermono, M.A.. The aim of this collaboration is to develop a research program that allows the study of the Indonesian marine biodiversity as a source of new antitumor compounds.
Under the terms of this agreement the foundations are laid, through which PharmaMar and the RCO-LIPI can work together in the collection of marine invertebrates, in the isolating of new marine bacteria and in the identification of new antitumor compounds. This collaboration will also permit the exchange of knowledge between the two institutions.
In the words of Mr. José María Fernández, President of PharmaMar, “for us, investing in R&D is crucial for the advancement of science, and the Memorandum with the Indonesian Research Center for Oceanography is a clear example of this,” adding, “we are sure that this alliance will reinforce our mission and commitment in the research against cancer, to enable us to respond to unmet medical needs, even more.”.
Dr. Dirhamsyah, MA, Director of Research of the RCO – LIPI, has explained that “we are proud
Article originally posted at